Saturday, November 23, 2024
HomeTagsEAHAD 2022

EAHAD 2022

Final Analysis of Pivotal HOPE-B Study Demonstrates Durable and Sustained Therapeutic Effect of Etranacogene Dezaparvovec Gene Therapy

Global biotherapeutics leader CSL Behring announced positive long-term results from the Phase 3 HOPE-B clinical trial evaluating etranacogene dezaparvovec (EtranaDez), an investigational adeno-associated virus...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics